What is the quality of the Laos Lucius version of the generic version of Brigatinib (Brigatinib), how to buy it, and how much does it cost?

In the field of lung cancer treatment, brigatinib, as a highly efficient targeted drug, brings hope to patients withALK-positive non-small cell lung cancer. However, the high price of original drugs prohibits many patients. At this time, Laos Lucius Pharmaceutical Factory successfully copied brigatinib, providing patients with a more affordable treatment option. This article will introduce in detail the quality, purchase method and price of Lucius version of brigatinib (trade name: LuciBriga) in Laos.

1. Quality

The Lao Lucius version of brigatinib has been approved by the Lao government and is a regular drug approved by the Ministry of Health. This means that the drug has reached certain standards in terms of production technology, quality control, etc., and its quality is guaranteed.

2. Purchase methods

For patients who want to purchase the Laos version of brigatinib, there are several options. One way is to go to Laos to buy locally in person, but this may involve higher travel costs and certain risks. Another more convenient way is to purchase through the services of professional overseas medical institutions. These institutions usually have cooperative relationships with local pharmaceutical factories in Laos and can provide drugs from formal channels and ensure the safety and quality of drugs. It is important for patients to choose a reputable institution.

3. Price

The price of the Laos Lucius version of brigatinib is more affordable than the original drug. A box of 90mg*30 tablets is priced at more than 900 RMB, and a box of 180mg*30 tablets is priced at more than 1,000 RMB. Compared with the price of original research drugs, which can easily reach tens of thousands of yuan, this price undoubtedly reduces the huge financial burden for patients. Patients can choose the appropriate specifications and purchase quantity according to their own condition and financial status.

In summary, Lao Lucius version of brigatinib, as an affordable generic drug, provides a new treatment option for patients with ALK-positive non-small cell lung cancer. Its quality is guaranteed and its purchase method is relatively convenient. However, patients still need to be cautious when purchasing and using, make sure to purchase through formal channels, and use drugs rationally under the guidance of a doctor.